Encoded at 3p14.2 (1), the most fragile site in the human genome (2) , Fhit is a dimeric protein of 147 amino acids with diadenosine triphosphate (ApppA) 1 hydrolase activity (3) . Because of the fragility of the FHIT chromosomal location, allele loss at FHIT, the earliest and most frequent known event in lung carcinogenesis (4, 5) , could have been considered either a cause or a consequence of cancer. Suppression of tumor formation by reexpression of Fhit protein in kidney, gastric, and lung cancer cell lines with FHIT deletions demonstrated that Fhit is an authentic tumor suppressor (6) . In lung cancer suppressor systems, suppression of tumorigenesis is accompanied by induction of apoptosis (7, 8) . In mice, FHIT inactivation induces stomach and sebaceous tumors that resemble human MuirTorre syndrome. 2 As anticipated from structural similarity between histidine triad (HIT) protein dimers and galactose-1-phosphate uridylyltransferase (GalT) (9) , Fhit proceeds through a GalT-like (10) , covalent His-96-adenylate intermediate that is hydrolyzed with retention of configuration (11) . The His-96 3 Asn allele of Fhit, which is more than a millionfold reduced in k cat and intermediate formation (12) , is nonetheless functional in tumor suppression (6) . Because this mutant protein retains ApppA binding in the low micromolar range, it was hypothesized that the tumor-suppressing function of Fhit consists of the ability to form complexes with substrates rather than cleavage of diadenosine polyphosphates (Ap n A) (12) . Much as G-proteins are receptors for regulated GTP binding and hydrolysis that transmit a signal as enzyme-substrate complexes, Fhit protein has been hypothesized to signal for apoptosis as an enzyme-substrate complex (13, 14) . An alternative but not exclusive model suggests that the tumor-suppressing function of Fhit may depend on promoting microtubule assembly (15) .
To determine the structural consequences of Ap n A substrate binding, stable complexes of wild-type and mutant Fhit proteins bound to nonhydrolyzable ApppA analogs were prepared (16, 17) . Co-crystal structures indicated that the Fhit dimer binds two Ap n A molecules in a manner that fills a large, positively charged groove with substrate phosphates, potentially presenting an altered surface for protein-protein interactions to a proapoptotic effector (12) . Because this model of Fhit function depends on forming complexes with inabundant substrates, and recognition (and stabilization) of these complexes by a Fhit effector, it was important to assay the more abundant cellular mononucleotides as competitive inhibitors of Fhit. To a first approximation, the cellular abundance of a Fhit-Ap n A complex is expected to be a function of the equilibrium binding constant of Fhit for that Ap n A, the binding constants of Fhit for competing compounds, the abundance of Fhit and each compound, and the lifetimes of these complexes, potentially as modulated by cellular proteins.
In 1 The abbreviations used are: ApppA, diadenosine triphosphate; HIT, histidine triad; GalT, galactose-1-phosphate uridylyltransferase; Ap n A, diadenosine polyphosphate; AMC, 7-diethylamino-4-methylcoumarin; BODIPY FL, 4 -4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacine-3-yl; ATP␥S, adenosine 5Ј-O-(3-thiotriphosphate); GTP␥S, guanosine 5Ј-O-(3-thiotriphosphate); TLC, thin layer chromatography; ATP␣S, adenosine 5Ј-O-(1-thiotriphosphate); GTP␣S, guanosine 5Ј-O-(1-thiotriphosphate). (20) . Here, we synthesized novel fluorescent analogs of ApppA by joining thiol-reactive derivatives of 7-diethylamino-4-methylcoumarin (AMC) and 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacine-3-yl (BODIPY FL) to ATP␥S and GTP␥S. We characterized the resulting ApppAMC, ApppBO-DIPY, and GpppBODIPY compounds biochemically and found them to be sensitive probes of Fhit activity. Despite a lack of any fluorescence acceptor function on guanine, GpppBODIPY had fluorescence that was more than 5-fold quenched relative to parental BODIPY compounds and with respect to the ppBO-DIPY enzymatic product. Proton NMR measurements reported herein provide evidence for the proximity of the guanine to BODIPY, suggesting that BODIPY fluorescence is quenched by a stacked or collisional mechanism (21) .
Having developed fluorescent and fluorogenic assays for the Fhit active site, we titrated unlabeled competitive inhibitors into these assay to determine the K m of Fhit for ApppA, AppppA, ApppppA, ATP␣S, and GTP␣S, and the K I of Fhit for AMP, inorganic pyrophosphate, and monophosphate. Surprisingly, pyrophosphate competes 10-fold better for the Fhit active site than do purine mononucleotides. The results indicate that the ability of Fhit to function as an Ap n A-dependent signaling protein in epithelial tumor suppression may depend on a hierarchy of competing compounds: Ap n A competing out pyrophosphate, and pyrophosphate competing out purine mononucleotides.
EXPERIMENTAL PROCEDURES
Synthesis of ApppAMC, ApppBODIPY, and GpppBODIPY-ATP␥S or GTP␥S tetralithium salts (25 mg, Sigma 85% pure, 0.05 mmol) were dissolved in 3 ml of water, buffered to pH 9.0 with sodium bicarbonate. Equimolar amounts of thiol-reactive fluorescent dyes (7-diethylamino-3-(4Ј-maleimidylphenyl)-4-methylcoumarin (22) or N-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacine-3-yl)methyl)iodoacetamide (23), Molecular Probes) were added in 3.0 ml of dioxane. Reactions were stirred and monitored by silica gel TLC, using dioxane:2-propanol: water:ammonium hydroxide (40:20:35:35) as the mobile phase. ATP␥S, GTP␥S, and the unreacted dyes migrated with R F values of 0.25, 0.20, and 0.95, respectively, while fluorescent adenosine nucleotide products had an R F of 0.7 and GpppBODIPY had an R F of 0.65. When, after several hours, reactions were judged complete by TLC, the resulting solutions were concentrated via rotary evaporation to 2 ml. Crude products were applied to an aqueous 2 ϫ 30-cm column of Sephadex LH-20 (Amersham Pharmacia Biotech). Pooling and lyophilization of pure product fractions afforded nucleotide-dye conjugates as their sodium salts with 76 -86% yield. For ApppAMC 
In these experiments, the value for k cat /K m , although treated as an independent variable, was always within 15% of the experimentally determined value. Fluorogenic Enzyme Assays-Reactions in black 96-well plates containing GpppBODIPY at 1.25-40 M in 60 l of 20 mM Na HEPES, pH 7.0, 0.5 mM MnCl 2 , and 0.2 mg/ml bovine serum albumin were initiated with addition of 167 fmol of Fhit and incubated for 300 -360 s at 37°C. Duplicate reactions were stopped by addition of 60 l of 200 mM sodium citrate, pH 3.0, and read with a Wallach Victor 2 Multilabel Counter 1420 with a 485-nm excitation filer and a 535-nm emission filter. At each substrate concentration, mock reactions were created by mixing 0%, 5%, and 10% volumes of acid-stopped complete hydrolysates with acid-stopped mock reactions (100%, 95%, and 90%). Fluorescent emissions of experimental and mock reactions were counted and plotted to calculate ppBODIPY production per active site per second at each concentration of GpppBODIPY. To prove that ApppA, pyrophosphate, and AMP are competitive inhibitors, these compounds were titrated into 96-well GpppBODIPY assays at four concentrations at each of five concentrations of GpppBODIPY (2, 4, 8, 16 , and 32 M). Initial rates as a function of GpppBODIPY and inhibitor concentration were plotted by the method of Eadie and Hofstee (24) .
RESULTS

Design Criteria for Fluorescent Fhit
Substrates-HIT proteins are a superfamily of homodimeric nucleotide-binding proteins with a unique mode of nucleotide recognition (14) . Each monomer contributes 5 strands to a 10-stranded anti-parallel ␤ sheet that forms two identical purine nucleotide-binding sites (9, 12, 25) . In Hint dimers, the two nucleotide-binding sites accommodate two equivalents of AMP or GMP with the ␣ phosphates proximal to the catalytic histidines (9) . In Fhit dimers bound to Ap n A, one pair of AMP moieties are buried proximal to the catalytic histidines with polyphosphate chains extending from the tightly bound AMP groups to expose the second pair of adenosines in a solvent-accessible site near Thr-79 (12) . Because Fhit tolerates substitutions of the second adenosine (3, 11), we expected that Fhit would hydrolyze ApppX-type substrates to produce AMP plus ppX. Thiol-reactive fluorescent dyes, 7-diethylamino-3-(4Ј-maleimidylphenyl)-4-methylcoumarin (22) and BODIPY FL C 1 -iodoacetamide (23), which were initially synthesized to label protein thiols, were reacted with ATP␥S to generate first generation fluorescent compounds, ApppAMC and ApppBODIPY. The second generation substrate, GpppBODIPY, was made by conjugating BODIPY FL C 1 -iodoacetamide to GTP␥S. Fluorescent substrates are depicted in Fig. 1 .
Fluorescent ApppA Analogs Are Good Fhit Substrates-At substrate concentrations below K m , reactions proceed with first-order kinetics such that the negative slope of a plot of log[remaining substrate] against time equals k cat /K m times the enzyme concentration (24) . To test whether Fhit would tolerate substitution of one adenosine in a fluorescent ApppA analog, we incubated 0.5-2.5 nM Fhit with 1.5-5 M ApppAMC and ApppBODIPY. Time courses of such reactions, analyzed by TLC and digitally imaged upon UV illumination, made it clear that Fhit cleaves each substrate, generating one fluorescent product with reduced chromatographic mobility (Fig. 2, A and  B) . One thousand times more concentrated substrates were required to visualize the nonfluorescent product by UV shadowing on TLC plates with fluorescent indicator (12) and, as expected, that product was indistinguishable from AMP (data not shown). Thus, Fhit cleaves ApppAMC and ApppBODIPY to produce AMP ϩ ppAMC and AMP ϩ ppBODIPY, respectively.
At an initial substrate concentration of 3 M ApppAMC ([enzyme] ϭ 2.5 nM) or 1.5 M ApppBODIPY ([enzyme] ϭ 1.2 nM), the first-order decay kinetics of ApppAMC and ApppBODIPY were examined. As shown in Fig. 3 (A and B) and Table I (12)). Initial rates as a function of ApppBODIPY concentration were measured and revealed that the basis for the catalytic disadvantage is in the k cat term. While the K m for ApppBODIPY, 3.0 M, is less than 60% higher than that for ApppA, the k cat for Appp-BODIPY, 7.3 s Ϫ1 , is 10-fold lower than that for ApppA ( Table I ). Considering that ApppBODIPY is an ApppX-type compound, containing an unaltered adenylating functionality (11), it is interesting to consider why the BODIPY substitution affects k cat rather than K m . Retention of a low K m at the expense of reduced k cat could indicate that ApppBODIPY has multiple binding modes, only some of which are productive, or that ppBODIPY is not as good a leaving group as ADP. Thus, the 10-fold reduction in k cat might correspond to the reciprocal fraction of time ApppBODIPY is in a productive, ApppA-type conformation or a tendency of the ppBODIPY product to reattack His-96-AMP rather than exiting the active site.
GpppBODIPY Is a Stacked and Quenched Fluorogenic Substrate-Cleavage of ApppG by Fhit yielded a two-thirds mixture of AMP ϩ GDP with a one-third mixture of GMP ϩ ADP (3). Thus, the guanine in GpppBODIPY was expected to be an acceptable substitution for adenine in ApppBODIPY. Upon synthesis, GpppBODIPY was found to have only 11% of the fluorescence in aqueous solution of the parental dye. Because guanine does not absorb photons in the visible range, fluorescent resonance energy transfer was ruled out as the mechanism of quenching. In methanol, the yield of GpppBODIPY fluorescence rose to 60% that of BODIPY fluorescence, suggesting that a solvent-sensitive binding interaction between guanine and BODIPY is responsible for quenching. The NMR signal in D 2 O for the guanine C-8 proton was shifted from 8. ) and that cleavage to ppBODIPY produces a 5.4-fold increase in fluorescence. The fluorogenic nature of GpppBODIPY allowed us to measure hydrolysis continuously or as stopped end points in a multiwell fluorescent plate reader. As shown in Table I , substitution of guanine for adenine reduces k cat 10-fold while reducing K m 2-fold. In the crystal structure of Hint-GMP, the carbonyl oxygen of His-42 makes a buried hydrogen bond to the N-2 nitrogen of GMP (9) . A similar interaction in Fhit could be positioning the GMP moiety of GpppBODIPY nonoptimally for catalysis and/or changing the rate-limiting step of the reaction.
Nucleotides and Nucleotide Analogs as Competitive Inhibitors of Fhit-ApppBODIPY and GpppBODIPY Kinetics-
The readout of first-order ApppBODIPY assays, k cat /K m times enzyme concentration, is well suited for assays of competitive inhibitors. Competitive inhibitors rob from the pool of available enzyme, decreasing k cat /K m (apparent) . The decrease in k cat /K m (apparent) is a function of the equilibrium binding constant and the concentration of the competitor. When the competing ligand is not a substrate, the equilibrium binding constant represents K I . When the competing ligand is itself a Fhit substrate, the equilibrium binding constant is K m , the apparent dissociation constant for all bound forms with enzyme.
As shown in Fig. 4 and summarized in Table I , Ap n A compounds, purine mononucleotides, inorganic pyrophosphate, and monophosphate were titrated into ApppBODIPY assays as competitive inhibitors. ApppA and AppppA displayed the lowest K m values. The K m for ApppA measured as a competing substrate was 2.0 Ϯ 0.2 M, consistent with the K m value measured for ApppA by 3 H product formation, 1.9 Ϯ 0.2 M (12). The additional phosphate group and two phosphate groups in AppppA and ApppppA increased K m by 30% and 600%, respectively. The next best competitor was inorganic pyrophosphate with a K I of 19.9 Ϯ 3.8 M. ATP and GTP, probably the most abundant cellular mononucleotides (26) , were difficult to fit to Equation 1 (see "Experimental Procedures"), potentially because of formation of pyrophosphate. To estimate the K m values of ATP and GTP, the slowly hydrolyzed ␣S forms of these nucleotides (11) were examined. All purine mononucleotides tested had K I and K m values approximately 10-fold higher than that of pyrophosphate. Monophosphate, on the other hand, inhibited with a K I of 2.9 Ϯ 0.4 mM.
To prove that the compounds inhibit competitively, rather than by a noncompetitive or uncompetitive mechanism, compounds were titrated into fluorogenic GpppBODIPY initial-rate assays over a range of substrate and inhibitor concentrations. As shown in Fig. 5 , ApppA, pyrophosphate, and AMP all increase the apparent K m of GpppBODIPY without affecting the k cat value, displaying the classical signature of competitive inhibitors in Eadie-Hofstee plots. These experiments also demonstrated that, much as the BODIPY for adenosine substitution was responsible for a 10-fold decrease in k cat with minimal effect on K m , the guanine for adenine substitution is responsible for a 10-fold decrease in k cat with minimal effect on K m .
DISCUSSION
The new compounds described herein can be considered analogs of ATP and GTP as well as Ap n A and have potential uses with a wide variety of enzymes including ATPases and GTPases. The compounds have been used to purify and characterize the Fhit active site of NitFhit, 3 the Fhit ortholog in Caenorhabditis elegans that is fused to Nit (27) , a tetrameric protein that binds two Fhit dimers and confers a novel protein- association activity to the complex. 3 In addition to basic science applications, by combining the fluorogenic Fhit substrate with newly developed Fhit-specific inhibitors (28), a Fhit diagnostic kit can be developed for use in clinical laboratories. The GpppBODIPY assay for Fhit, as a 96-well fluorogenic assay, is also suitable for a high throughput screen for inhibitors. Among Fhit inhibitors, uncompetitive compounds (those that bind and retard the enzyme-substrate complex) might include compounds that are competitive with a Fhit effector (12, 13) .
The present study provides valuable information about properties of substrates and related compounds that determine binding to Fhit. Fhit-Ap n A complexes may be required for signaling (12) , and formation of these complexes would have to occur in the face of competition with mononucleotides, monophosphate, pyrophosphate, and other compounds. The finding that reversible binding constants for Ap n A, pyrophosphate, and purine mononucleotides are 2 EϪ6, 2 EϪ5, and 2 EϪ4 M, respectively, suggests that Fhit may have evolved a hierarchical system to avail itself of Ap n A in the presence of competing compounds. Prior to our measurements of pyrophosphate and purine mononucleotides as competitive inhibitors of Fhit, one might have expected that the ground state of Fhit would be ATP-bound. Indeed, if purine mononucleotides are at low millimolar levels (26), 10 times their equilibrium-binding constants, ϳ90% of Fhit would be occupied by mononucleotides in the absence of other competitors. Table I , we calculate that a spike of ϳ100 M Ap n A would convert half the Fhit-pyrophosphate to Fhit-Ap n A. Conditions that lead to dramatic increases in Ap n A levels include interferon (31) and etoposide (32) treatment of promyelocytes, and administration of glucose to pancreatic ␤ cells (33) .
The data presented herein illustrate a surprising degree of k cat discrimination among chemically similar substrates. Although the kinetics of Fhit-dependent cleavage of ApppA are robust, the function of Fhit appears to depend not on cleavage but binding Ap n A substrates (5, 6, 12) . We have argued that important Fhit substrates are those with low K m values but not necessarily the highest k cat values. Less optimal substrates, such as AppppA, may be more important than ApppA if they are more abundant and if their residence time on Fhit is longer than that of ApppA (12) . In the cell, the lifetime of Fhitsubstrate complexes may be stabilized by effector interactions. The observation that substrates with fundamentally unaltered chemical lability such as ApppBODIPY and GpppBODIPY are cleaved with reduced k cat values suggests that Fhit has binding modes that are at least 100-fold stabilized with respect to optimized in vitro kinetics.
The stereochemical course of the Fhit reaction (11) dictates that ADP (in case of ApppA), ATP (in case of AppppA), or ppBODIPY (in case of fluorescent substrates) must leave before the hydrolytic water can be bound by the enzyme. Thus, any Fhit or Fhit-effector conformation that prevents leaving-group exit or blocks water entry would be expected to retard substrate hydrolysis. The 20 M pyrophosphate-binding site that is competitive with substrate is a likely facilitator of leaving groupreattack. A Fhit effector may stabilize Fhit-Ap n A by pinning the leaving group down on this site.
Many intracellular and extracellular receptors are enzymatically inert, while others, such as GTPases, are slow enzymes with intrinsically long-lived enzyme-substrate complexes. Fhit appears to be a receptor for Ap n A with rapid kinetics but with features that allow it to be stabilized in vivo. The kinetics and structural biology of Fhit-associated proteins (15, 27) are expected to shed more light on this matter.
